TP53 and ovarian carcinoma: Even more, interesting crosstalk between p53- and STAT3-signaling pathways, by the intervention of PI3K and MAPK signaling, has been recently reported in ovarian cancer [41] and linked to an aggressive phenotype mediated by the epithelial–mesenchymal transition, resulting in cell metastasis and chemoresistance.